Ruby Bio

What Ruby Bio does

Ruby Bio is a California-based biosynthesis company that operates a proprietary non-GMO yeast-based fermentation platform licensed from UC Davis to convert low-cost sugars and waste feedstocks into high-value, biodegradable, non-toxic biochemicals. Its product portfolio spans five categories: biosurfactants and bio-based surfactants for personal care and home care; natural food emulsifiers targeting lecithin, polysorbate, and DATEM replacements in baked goods, beverages, and confectionery; fermentation-produced polyol sweeteners (mannitol, erythritol, arabitol); polymer building blocks for polyurethanes, polyesters, polyamides, and coatings; and fermentation-derived oleochemicals (fatty alcohols, fatty acids, hydroxy fatty acids) in standard C8/C10, C12/C14, and C16/C18 compositions.

The company sells ingredients directly to enterprise Consumer Packaged Goods manufacturers via a [email protected] channel, with samples and quotes negotiated per inquiry. Its go-to-market leverages accelerator participation—selected for Mondelēz International's CoLab Tech 2026 cohort and the BEAM Circular Accelerator's second cohort—to build strategic relationships with major food and consumer goods companies and access pilot pathways. Manufacturing is stated to be running at commercial scale, and the company reports a 2026 fermentation breakthrough achieving titers exceeding 100g per litre for clean-label emulsifiers, positioning the platform to compete on cost with synthetic alternatives while remaining palm-free and petroleum-free.

Ruby Bio is led by CEO and co-founder Charlie Silver, a multi-time entrepreneur who previously co-founded Mission Bio and led technology roles at Agilent, Novelx, and Glimmerglass Networks, and CTO and co-founder Pavan Kambam, whose biosynthesis scale-up experience includes Eat Just (first worldwide cultured chicken regulatory approval), Clara Foods, and Greenlight. SVP of Business Development Mark Horan anchors the commercial side with prior global sales leadership at BASF, Cognis, Henkel, and TRI-K. The company has raised approximately $7.98M in disclosed funding, most recently in June 2025 with participation from Alumni Ventures.

Name

Ruby Bio

Legal name

Ruby Bio

Website

https://rubybio.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

Ruby Bio is a California biosynthesis company using a UC Davis-licensed non-GMO yeast platform to manufacture palm-free, biodegradable biosurfactants, food emulsifiers, sweeteners, polymer building blocks, and oleochemicals for enterprise CPG customers.

Ownership category

akta.pro rank

Product category

Specialty Biochemicals

NAICS

Sugar and Confectionery Product Manufacturing (3113), Starch and Vegetable Fats and Oils Manufacturing (31122), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Sugar & Confectionery Products (2060), Food And Kindred Products (2000)

akta.pro primary industry

Bio-based Surfactants, Detergent Ingredients & Oleochemicals (EUAAAIAE)

akta.pro secondary industries

Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors) (EUAAAIAJ), Bio-based Resins, Adhesives, Coatings & Sealants (EUAAAIAG), Enzymes & Industrial Biotechnology Inputs (Enzymes, Microbial Strains, Fermentation Aids) (EUAAAIAL), Biochemicals & Bio-based Platform Chemicals (cellulose sugars, lignin derivatives, organic acids) (IMAMALAB)

Keywords

• Biosurfactant manufacturing
• Food emulsifier production
• Fermentation technology
• Bio-based ingredients
• Oleochemical alternatives

Headquarters

HQ city

Oakland

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Technology or R&D, Personnel, Supply Chain, Marketing or Sales

Revenue model

1. Bio-based Ingredient Sales: Ruby Bio sells biosurfactants, food emulsifiers, polyol sweeteners, polymer building blocks, and oleochemicals as ingredients to CPG manufacturers. Products are offered as direct alternatives to synthetic or petroleum-derived chemicals.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Ruby Bio manufactures bio-based specialty ingredients — biosurfactants and bio-based surfactants, natural food emulsifiers, polyol sweeteners (mannitol, erythritol, arabitol), polymer building blocks (biomonomers), and oleochemicals — using a proprietary non-GMO yeast-based biosynthesis platform licensed from UC Davis that ferments low-cost sugar and waste feedstocks into biodegradable, non-toxic, palm-free and petroleum-free products at commercial scale.

Product overview

Ruby Bio operates as a biomanufacturing company built around a proprietary yeast-based biosynthesis platform licensed from UC Davis. The platform converts low-cost sugars and waste feedstocks into high-value biochemicals through fermentation. The product portfolio spans five core offerings: (1) Biosurfactants and Bio-based Surfactants for personal care and home care; (2) Natural Food Emulsifiers for baked goods, beverages, and confectionery; (3) Polyol Sweeteners including mannitol, erythritol, and arabitol; (4) Polymer Building Blocks (Biomonomers) for polyurethanes, polyesters, and polyamides; and (5) Oleochemicals from Fermentation including fatty alcohols and acids. All products are palm-free, petroleum-free, biodegradable, and non-toxic. Manufacturing is stated to be running at commercial scale.

Differentiator

Problem solved

Functional benefit

Products and services

• Biosurfactants and Bio-based Surfactants Full portfolio of multifunctional biosurfactants and bio-based surfactants (non-ionics and anionics spanning a wide range of hydrophilic-lipophilic balance) for personal care and home care applications including detergency, emulsification, solubilization, wetting, and dispersion in shampoos, soaps, and cleaning products. Palm-free, petroleum-free, biodegradable, and non-toxic.
• Natural Food Emulsifiers 100% natural, fermentation-derived food emulsifiers for boosting performance and shelf life of baked goods, beverages, and confectionery products. Serve as natural alternatives to traditional additives such as lecithins, triglycerides, polysorbates, DATEMs, and other synthetic ingredients, enabling clean and natural labeling.
• Polyol Sweeteners Fermentation-based, 100% natural polyol sweeteners including mannitol, erythritol, and arabitol (a natural polyol sweetener with nutraceutical benefits and no known association with gastric disorder) as alternatives to synthetic polyol sweeteners. Cost competitive with non-GMO options available.
• Polymer Building Blocks (Biomonomers) Bio-based biomonomers serving as functional replacements for monomers and building blocks used in polyurethanes, polyesters, polyamides, and other common polymers. 100% bio-based products produced from sugar or up-cycled waste feedstocks, targeting medium- and long-chain molecules for adhesives, coatings, lubricants, and packaging.
• Oleochemicals from Fermentation Medium- and long-chain fatty alcohols, fatty acids, hydroxy fatty acids, and corresponding esters derived from sugar or up-cycled waste feedstocks. Drop-in replacements for conventional oleochemicals with lower carbon intensity. Standard compositions include C8/C10, C12/C14, and C16/C18 alcohols and acids, plus discrete carbon chains or customized mixtures.

Quantifiable outcome

• Fermentation titers exceeding 100g per litre achieved for clean-label emulsifiers
• +2 more outcomes

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• Mondelēz InternationalcoreStrategic or Co-development Partner · 16 June 2026Ruby Bio was selected as one of nine startups for Mondelēz International's CoLab Tech 2026 accelerator program, the third cohort of the snack company's R&D-led initiative. The program focuses on emerging technologies addressing sustainability, supply chain challenges, ingredient innovation, and consumer experience enhancements. Ruby Bio was selected for its precision fermentation and functional ingredients solutions.
• BEAM Circular AcceleratorcoreStrategic or Co-development Partner · 18 March 2026Ruby Bio was selected as one of five biotechnology startups for BEAM Circular Accelerator's second cohort from 200 applicants. The 12-week hybrid program in California's North San Joaquin Valley provides $100,000 in total support including grants and incentive funding, along with access to mentors, investors, and the CA Bioeconomy Innovation Campus. The program is sponsored by Almond Board of California and State of California through CA Jobs First initiative.
• UC DaviscoreTechnology or IntegrationRuby Bio licenses its non-GMO yeast-based biosynthesis platform from UC Davis. The technology converts low-cost sugar into high-value emulsifiers. UC Davis research, including a yeast discovery, has paved the way for new eco-friendly cleaning products and sustainable biochemical production.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• C16 Biosciences: C16 Biosciences uses precision fermentation to produce palm oil alternatives and biosurfactants — directly overlapping with Ruby Bio's palm-free surfactant and oleochemical value proposition for personal care and home care markets.
• Solugen: Solugen manufactures bio-based specialty chemicals via enzymatic and fermentation processes, including bio-based surfactants and chelants. Ruby Bio's biosurfactant and oleochemical portfolio targets the same CPG and industrial buyers.
• Conagen: Conagen is a precision fermentation company developing ingredients including surfactants, sweeteners, and specialty biochemicals — directly comparable in technology platform and target ingredient categories to Ruby Bio.
• LanzaTech: LanzaTech uses gas fermentation to produce sustainable fuels and chemicals including specialty oleochemicals. Comparable as a fermentation platform producing bio-based specialty ingredients serving CPG and industrial customers.
• Locus Fermentation Solutions: Locus FS produces biosurfactants (e.g., sophorolipids) via fermentation for personal care, household, and industrial cleaning — directly competing with Ruby Bio's biosurfactant portfolio in the same end-use segments.
• Amyris: Amyris pioneered fermentation-derived specialty ingredients (squalene, sweeteners, biosurfactants) targeting CPG markets. Ruby Bio pursues a similar ingredient-displacement strategy with overlapping product categories like polyols and oleochemicals.

Emerging players

• Checkerspot: Checkerspot uses fermentation to produce novel bio-based polyols and oils for personal care, coatings, and polymer applications — overlapping with Ruby Bio's polyol sweetener and polymer building block offerings.
• Bolt Threads: Bolt Threads applies bio-based fermentation to produce specialty proteins and ingredients for cosmetics and materials. The company's bioprocessing capabilities overlap with Ruby Bio's fermentation platform approach.

Broad incumbents

• DSM-Firmenich: DSM-Firmenich is a global leader in food ingredients, flavors, and bioscience-based specialty ingredients including enzymes and fermentation-derived products. Ruby Bio competes with portions of its ingredient portfolio across food and personal care.
• BASF: BASF is a diversified chemical incumbent with a substantial bio-based surfactants, oleochemicals, and polymer intermediates portfolio. Ruby Bio's SVP BD Mark Horan previously led global sales at BASF, illustrating how Ruby Bio positions against incumbents in CPG supply chains.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds4 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ruby Bio